The Lexie B3 is a mid-priced OTC hearing aid available at $999, delivering strong overall performance with a SoundScore of 4.48/5 in our lab testing. This behind-the-ear device stands out in the OTC category, scoring 1.01 points above the category average of 3.47/5.
Speech clarity is a notable strength, with speech in quiet earning a strong 4.2/5—that's 1.55 points above the OTC category average. Speech in noise performance is above the category average by 0.90 points, though at 2.1/5 it remains mixed in absolute terms, reflecting the inherent challenge of noisy environments for OTC devices. Feedback handling is excellent at 4.6/5, essentially matching the already-high category standard.
Music streaming quality scores a solid 3.3/5, sitting 1.43 points above the category average of 1.87/5—a meaningful advantage for users who stream audio regularly. Own-voice comfort is solid at 3.0/5, half a point above average, suggesting reasonable occlusion management.
The Lexie B3 is well-suited for consumers seeking strong speech clarity and reliable streaming in a self-fit OTC package. Those prioritizing speech understanding in very noisy settings may want to consider whether the mixed absolute score in that area meets their needs. Budget-conscious shoppers should note that alternatives like the Elehear Delight offer lower prices, though with somewhat lower overall scores.
